IDiyas

For the Inventor, By the Inventor

Ushiku, Japan

Teruyuki Nishimura

USPTO Granted Patents = 15



Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Tsukuba, JP (2003 - 2007)
  • Ibaraki, JP (2010 - 2011)
  • Ushiku, JP (2008 - 2013)
  • Gotenba, JP (2013)
  • Shizuoka, JP (2014)

Company Filing History:

goldMedal9 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents
silverMedal6 out of 47 
 
Msd K.k.
 patents

Years Active: 2003-2014

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 8765789 - 2-pyridinecarboxamide derivatives (2014-07-01),
2. 8362052 - Isoindolin-1-one derivative (2013-01-29),
3. 8344003 - 2-pyridinecarboxamide derivatives (2013-01-01),
4. 8338460 - 2-pyridinecarboxamide derivative having GK-activating effect (2012-12-25),
5. 7994331 - Heterocycle-substituted benzimidazole derivative (2011-08-09),
6. 7932394 - Aryloxy-substituted benzimidazole derivatives (2011-04-26),
7. 7799820 - 2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions (2010-09-21),
8. 7754743 - Heteroarylcarbamoylbenzene derivatives (2010-07-13),
9. 7728025 - 2-heteroaryl-substituted benzimidazole derivative (2010-06-01),
10. 7687502 - Substituted quinazoline or pyridopyrimidine derivative (2010-03-30),
11. 7629362 - 2-pyridine carboxamide derivatives (2009-12-08),
12. 7432287 - Heteroarylcarbamoylbenzene derivative (2008-10-07),
13. 7253188 - Aminobenzamide derivative (2007-08-07),
14. 6777410 - Isoindole derivatives (2004-08-17),
15. 6608098 - Isoindole derivatives (2003-08-19),

Title: Teruyuki Nishimura: Innovator in Pharmaceutical Compounds

Introduction

Teruyuki Nishimura is a distinguished inventor based in Ushiku, Japan. With a remarkable portfolio of 15 patents, Nishimura has made significant contributions to the field of pharmaceuticals, particularly in developing compounds for therapeutic use in diabetes and other medical conditions.

Latest Patents

Among his latest innovations, Nishimura has developed 2-pyridinecarboxamide derivatives. This invention relates to compounds that activate glucokinase, thus serving as potential therapeutic agents for diabetes mellitus. These compounds are characterized by a complex formula that includes nitrogen, sulfur, and oxygen atoms, along with various aryl groups. Another notable patent is the Isoindolin-1-one derivative, which includes a structure that can accommodate a variety of substituents, enhancing its utility in medicinal chemistry. Both of these patents highlight his expertise in creating transformative medicinal compounds.

Career Highlights

Nishimura's career is marked by his work with prominent companies in the pharmaceutical industry, including Banyu Pharmaceutical Co. Ltd and MSD K.K. His experience in these organizations has bolstered his research and innovation capabilities, allowing him to focus on therapeutic solutions that can improve patient outcomes.

Collaborations

Throughout his career, Nishimura has collaborated with esteemed professionals, including Jun-ichi Eiki and Tomoharu Iino. These partnerships have provided a collaborative environment that fosters innovation and promotes the refinement of pharmaceutical compounds.

Conclusion

Teruyuki Nishimura’s contributions to the field of pharmaceuticals through his patents on therapeutic compounds underscore his role as an influential inventor. His innovative work continues to pave the way for new treatments and showcases the vital intersection of research and practical application in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…